BlackRock, Inc. 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 8:14 pm Sale | 2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 22,765,804 7.400% | -5,138,532 (-18.41%) | Filing |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 27,904,336 9.300% | 4,918,894 (+21.40%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 22,985,442 7.800% | 2,851,450 (+14.16%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 20,133,992 7.200% | 323,644 (+1.63%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 19,810,348 7.100% | -2,067,094 (-9.45%) | Filing |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | BlackRock Inc. BLK | 21,877,442 8.400% | 1,021,335 (+4.90%) | Filing |